Annual report pursuant to Section 13 and 15(d)

Revenue Recognition

v3.10.0.1
Revenue Recognition
12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
Revenue Recognition
6. Revenue Recognition

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of products and services, which when capable of being distinct, are accounted for as separate performance obligations. Revenue recognition is evaluated based on the following five steps: (i) identification of the contract with the customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract; and (v) recognition of revenue when or as a performance obligation is satisfied.
 
For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are determined based on observable prices at which the Company separately sells its products or services. If a standalone selling price is not directly observable, the Company estimates the selling price based on market conditions and entity-specific factors including features and functionality of the product and/or services, the geography of the Company’s customers, type of the Company’s markets. Any discounts or other reductions to the transaction price are allocated proportionately to all performance obligations within the multiple-element arrangement.
 
Contract Balances
 
Timing of revenue recognition may differ from the timing of invoicing to customers and receipt of payment. For the sale of its products, the Company generally recognizes revenue at a point in time through the ship-and-bill performance obligations. For the lease of its products, the Company generally recognizes revenue over the lease term commencing upon the completion of customer training. For service agreements, the Company generally invoices customers at the beginning of the coverage period and record revenue related to the billed amounts over time, equivalent to the coverage period of the maintenance and support contract.
 
Deferred revenue is comprised mainly of unearned revenue related to extended support and maintenance contracts (Ekso Care) but also includes other offerings for which the Company has been paid in advance and earns revenue when the Company transfers control of the product or service.
 
Deferred revenues consisted of the following:
 
December 31, 2018
 
December 31,
2017
Deferred extended maintenance and support
$
2,114

 
$
1,763

Deferred royalties
300

 

Deferred device revenues
70

 
31

Customer deposits and advances
62

 
52

Deferred rental income
51

 
73

Total deferred revenues
2,597

 
1,919

Less current portion
(1,102
)
 
(1,103
)
Deferred revenues, non-current
$
1,495

 
$
816

 
Deferred revenue activity consisted of the following:
 
December 31, 2018
Beginning balance
$
1,919

Deferral of revenue
2,230

Recognition of deferred revenue
(1,552
)
Ending balance
$
2,597


 
At December 31, 2018, the Company’s deferred revenue, was $2,597. Excluding customer deposits, the Company expects to recognize approximately $1,033 of the deferred revenue in 2019$738 in 2020, and $764 thereafter.

In addition to deferred revenue, the Company has non-cancellable backlog of $944  related to its contracts for rental units with its customers. These rental contracts are classified as operating leases, with typically 12-month lease terms.
 
As of December 31, 2018 and 2017, accounts receivable, net of allowance for doubtful accounts, were $3,660 and $2,760, respectively, and are included in current assets on the Company’s consolidated balance sheets.
 
The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days.
 
Disaggregation of revenue
 
The following table disaggregates the Company’s revenue by major source for the year ended December 31, 2018:
 
Medical
 
Industrial
 
Other
 
Total
Device revenue
$
6,403

 
$
2,360

 
$

 
$
8,763

Service, support and rentals
2,100

 

 

 
2,100

Parts and other
323

 
118

 

 
441

Collaborative arrangements

 

 
28

 
28

 
$
8,826

 
$
2,478

 
$
28

 
$
11,332